Arbutus Biopharma (ABUS) Tops Q1 EPS by 10c, Beat on Revenues
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- S&P 500, Nasdaq advance as oil eases ahead of Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| (NASDAQ: ABUS) | Delayed: 4.27 +0.07 (1.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.20 | 52 Week High | $5.88 | |||
| Open | $4.20 | 52 Week Low | $2.65 | |||
| Day High | $4.29 | P/E | N/A | |||
| Day Low | $4.18 | EPS | $0.00 | |||
| Volume | 370,067 | |||||
